Literature DB >> 11389493

Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.

E Ninin1, N Milpied, P Moreau, B André-Richet, N Morineau, B Mahé, M Vigier, B M Imbert, O Morin, J L Harousseau, H Richet.   

Abstract

The epidemiology of infections was studied in a retrospective cohort of 446 recipients of bone marrow transplants (BMTs; 92 of which were allogeneic and 354 of which were autologous) during 1993--1996. Infections that were microbiologically documented in 274 recipients included bacteremia, urinary tract infections, cytomegalovirus viremia, fungemia, invasive aspergillosis, and catheter-related infections. During the period of neutropenia, no differences were found between recipients of allogeneic BMTs and recipients of autologous BMTs with regard to the incidence and the nature of infection. After patients underwent engraftment, bacteremia, cytomegalovirus viremia, and invasive aspergillosis were significantly more common in recipients of allogeneic BMTs than in recipients of autologous BMTs. Deaths caused by infection were uncommon and were mainly the result of invasive aspergillosis. Therefore, empirical antimicrobial therapy should be the same for recipients of both allogeneic and autologous BMTs during the period of neutropenia; after engraftment, more attention should be paid to the risk of infection in allogeneic BMT recipients, particularly with regard to detection and prevention of invasive aspergillosis.

Entities:  

Mesh:

Year:  2001        PMID: 11389493     DOI: 10.1086/320871

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.

Authors:  R Parody; R Martino; R de la Cámara; A García-Noblejas; A Esquirol; I Garcia-Cadenas; T Villaescusa; D Caballero; M Rovira; F Fernandez-Avilés; F J Marquez-Malaver; I Espigado; C Castilla-Llorente; I Heras; M A Cabero; J R Cabrera; P Barba; D Valcarcel; I Sánchez-Ortega; R F Duarte; D Serrano; F Carretero; L Vazquez
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

2.  Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories.

Authors:  Arlo Upton; Anja Gugel; Wendy Leisenring; Ajit Limaye; Barbara Alexander; Randall Hayden; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Bacteremia During Early Post-allogeneic Hematopoietic Stem Cell Transplantation Period: A Single Center Experience.

Authors:  Amro Mohamed Sedky El-Ghammaz
Journal:  Indian J Hematol Blood Transfus       Date:  2016-06-29       Impact factor: 0.900

4.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

5.  Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).

Authors:  Diana Averbuch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Christina Orasch; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

Review 6.  Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients.

Authors:  Katherine A Baugh; Ifigeneia Tzannou; Ann M Leen
Journal:  Curr Opin Infect Dis       Date:  2018-08       Impact factor: 4.915

Review 7.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study.

Authors:  Ashrit Multani; Libby S Allard; Tamna Wangjam; R Alejandro Sica; David J Epstein; Andrew R Rezvani; Dora Y Ho
Journal:  Blood Adv       Date:  2019-11-26

9.  Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.

Authors:  Tobias Lahmer; Sebastian Rasch; Christopher Schnappauf; Analena Beitz; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2016-05-03       Impact factor: 2.574

10.  Invasive pulmonary aspergillosis 10 years post bone marrow transplantation: a case report.

Authors:  Rifat Rashid; David W Denning
Journal:  J Med Case Rep       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.